Helmut Gottlieb, Ph.D.
ASSOCIATE PROFESSOR, PHARMACEUTICAL SCIENCES
PHONE: (210) 883-1074
Dr. Gottlieb completed his undergraduate studies at Texas A&M-Kingsville. Soon after, he moved to New Orleans where he pursued his doctoral dissertation research under the supervision of Dr. Daniel Kapusta at LSU Health Sciences Center. After successful defense of his dissertation, titled Water Diuretic Properties of kappa Opioids: CNS Sites, Mechanisms, and Functions, Dr. Gottlieb obtained a Ph.D. in Pharmacology and moved to San Antonio in 2004 to pursue postdoctoral research at UTHSCSA Department of Pharmacology under the guidance of Dr. JT Cunningham.
Dr. Gottlieb’s current research combines whole animal integrative pharmacology/physiology with functional neuroanatomy and molecular biology to understand the role opioid systems play in the regulation of fluid and electrolyte balance, and cardiovascular function. This research is crucial for the prevention and treatment of a number of diseases, as well as to the development of new therapeutics. Dr. Gottlieb has presented his work at national and international meetings, and his work has been published in journals such as the Journal of Pharmacology and Experimental Therapeutics, American Journal of Physiology, Journal of Neuroendocrinology, and Experimental Neurology. Dr. Gottlieb has acquired research funding from NIH and several intramural grants.
Dr. Gottlieb is primarily involved in teaching Pharmacology and coordinating two of the twelve Therapeutics modules. These include Pharmacotherapeutics II (Introduction to Pharmacology) and Pharmacotherapeutics V (Cardiovascular Disorders). Dr. Gottlieb also teaches pharmacology in the Pharmacotherapeutics VI (Pulmonary Disease), at the Rosenberg School of Optometry and Ila Faye Miller School of Nursing (Advanced Practice Nursing).
In addition to Dr. Gottlieb scholarly activities, he is a member of a number of professional societies which include the American Society for Pharmacology and Experimental Therapeutics (ASPET), the American Physiological Society (APS), and American Association of Colleges of Pharmacy (AACP). Within those societies, he has served in the APS International Physiology Committee and the ASPET Diversity Committee and Division of Pharmacology Education Executive Committee.